JANUS HENDERSON GROUP PLC - 30 Jun 2025 SCHEDULE 13G/A Report for BRIGHT MINDS BIOSCIENCES INC. Common Stock (DRUG)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
BRIGHT MINDS BIOSCIENCES INC. Common Stock
Symbol
DRUG
Shares outstanding
7,028,589 shares
Disclosed Ownership
1,145,660 shares
Ownership
16.3%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 10:58:45 UTC
Date of event
30 Jun 2025
Previous filing
07 Apr 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 16.3% 1,145,660 0 1,145,660 Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 14% 984,485 0 984,485 Kristin Mariani Head of North America Compliance, CCO